Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI

Diagnostic and Interventional Radiology

Volumn 21, Issue 2, 2015, Pages 96-104

  Asayama, Yoshiki ^a   Nishie, Akihiro ^a   Ishigami, Kousei ^a   Ushijima, Yasuhiro ^a   Takayama, Yukihisa ^a   Fujita, Nobuhiro ^a   Kubo, Yuichiro ^a   Aishima, Shinichi ^a   Shirabe, Ken ^a   Yoshiura, Takashi ^a   Honda, Hiroshi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DECARBOXYPROTHROMBIN; GADOXETIC ACID; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ECHO PLANAR IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGING SYSTEM; LIVER CELL CARCINOMA; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; SIGNAL DETECTION; TUMOR DIFFERENTIATION; TUMOR VOLUME; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; LIVER NEOPLASMS; PROCEDURES;

AGED; BILE DUCT NEOPLASMS; CARCINOMA, HEPATOCELLULAR; CHOLANGIOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 84924664480     PISSN: 13053825     EISSN: 13053612     Source Type: Journal    
DOI: 10.5152/dir.2014.13013     Document Type: Article

References (25)

1. The Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 5th ed. Tokyo: Kanehara, 2008.
2. Lim JH. Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. AJR Am J Roentgenol 2003; 181:819-827. [CrossRef].
3. Asayama Y, Yoshimitsu K, Irie H, et al. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma. Radiology 2006; 238:150-155. [CrossRef].
4. Maetani Y, Itoh K, Watanabe C, et al. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. AJR Am J Roentgenol 2001; 176:1499-1507. [CrossRef].
5. Lacomis JM, Baron RL, Oliver JH 3rd, Nalesnik MA, Federle MP. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 1997; 203:98-104. [CrossRef].
6. Kutami R, Nakashima Y, Nakashima O, Shiota K, Kojiro M. Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 2000; 33:282-289. [CrossRef].
7. Asayama Y, Yoshimitsu K, Nishihara Y, et al. Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. AJR Am J Roentgenol 2008; 190:W28-34. [CrossRef].
8. Bruegel M, Holzapfel K, Gaa J, et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 2008; 18:477-485. [CrossRef].
9. Ringe KI, Husarik DB, Sirlin CB, Merkle EM. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 2010; 195:13-28. [CrossRef].
10. Asayama Y, Tajima T, Nishie A, et al. Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production. Eur J Radiol 2011; 80:e243-248. [CrossRef].
11. Ishigami K, Yoshimitsu K, Nishihara Y, et al. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings. Radiology 2009; 250:435-443. [CrossRef].
12. Clement O, Muhler A, Vexler V, Berthezene Y, Brasch RC. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats. Invest Radiol 1992; 27:612-619. [CrossRef].
13. Tsuda N, Kato N, Murayama C, Narazaki M, Yokawa T. Potential for differential diagnosis with gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in experimental hepatic tumors. Invest Radiol 2004; 39:80-88. [CrossRef].
14. Tanimoto A, Lee JM, Murakami T, Huppertz A, Kudo M, Grazioli L. Consensus report of the 2nd International Forum for Liver MRI. Eur Radiol 2009; 19 (Suppl 5):S975-989. [CrossRef].
15. Wood R, Bassett K, Foerster T, Spry C, Tong L. 1.5 Tesla magnetic resonance imaging scanners compared with 3.0 Tesla magnetic resonance imaging scanners: systematic review of clinical effectiveness. CADTH Technol Overv 2012; 2:e2201.
16. Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M. Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma. Hepatology 1992; 15:843-848. [CrossRef].
17. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40:715-724. [CrossRef].
18. Goshima S, Kanematsu M, Watanabe H, et al. Hepatic hemangioma and metastasis: differentiation with gadoxetate disodium-enhanced 3-T MRI. AJR Am J Roentgenol 2010; 195:941-946. [CrossRef].
19. Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology 1992; 183:59-64. [CrossRef].
20. Itai Y, Ohtomo K, Kokubo T, et al. CT of hepatic masses: significance of prolonged and delayed enhancement. AJR Am J Roentgenol 1986; 146:729-733. [CrossRef].
21. Kang Y, Lee JM, Kim SH, Han JK, Choi BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 2012; 264:751-760. [CrossRef].
22. Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 2011; 21:2056-2066. [CrossRef].
23. Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM. "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor. AJR Am J Roentgenol 2009; 193:W490-496. [CrossRef].
24. Grazioli L, Olivetti L, Fugazzola C, et al. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology. Eur Radiol 1999; 9:62-67. [CrossRef].
25. Nishie A, Tajima T, Asayama Y, et al. Diagnostic performance of apparent diffusion coefficient for predicting histological grade of hepatocellular carcinoma. Eur J Radiol 2011; 80:e29-33. [CrossRef].